Non-contact Sleep Apnea Identification in Neurological Rehabilitation

Sponsor
Sleepiz AG (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04803552
Collaborator
(none)
67
1
1
16.5
4.1

Study Details

Study Description

Brief Summary

To improve the quality of medical care in the group of poststroke patients, we are planning to examine neurological patients in a rehabilitation clinic simultaneously with a non-contact method (Sleepiz One) and a standard diagnostic polygraphy measurement. This easy and comfortable pre-screening (Sleepiz One) should reduce the barrier for ward physicians to request a sleep study. The method could help to overcome the bottleneck of resource-intense procedures. It is simple to carry out and does not disturb the sleep of the patients.

The scoring is done according to the AASM Manual Version 2.6. Patients with a confirmed diagnosis will be informed about therapy options by a sleep physician and receive a recommendation for further therapy in the discharge letter from the rehabilitation clinic.

The goal of the study is then to evaluate if a non-contact method, the Sleepiz One, presents an opportunity for a fast and easy pre-screening during rehabilitation. Therefore, the precision of binary classification of subjects based on their sleep apnea severity (AHI >= 15) made by Sleepiz One will be compared to PG data manually scored by expert sleep scorers.

Condition or Disease Intervention/Treatment Phase
  • Device: Overnight sleep study with Sleepiz One and a respiratory polygraphy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
67 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Identification of Patients With Clinically Relevant Sleep Apnea With a Contactless Device in Rehabilitation Clinic
Actual Study Start Date :
Apr 15, 2021
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Contactless sleep apnea screening vs respiratory polygraphy

Device: Overnight sleep study with Sleepiz One and a respiratory polygraphy
Participants will undergo a screening night with Sleepiz One. and with a cardiorespiratory polygraphy device (Miniscreen, Heinen-Löwenstein). Measurements (Miniscreen, Heinen-Löwenstein) Thoracic respiratory effort: respiration frequency (BR), respiration curve Airflow: respiration frequency (BR), respiration curve Body movement: body position Blood oxygen saturation (SpO2) Pulse Measurements (Sleepiz One): • Movement originating from breathing and heart contractions

Outcome Measures

Primary Outcome Measures

  1. Binary classification of the apnea severity [1 night]

    Precision of binary classification of subjects based on their sleep apnea severity (apnea-hypopnea index (AHI) >= 15) made by Sleepiz One, compared to PG data manually scored by expert sleep scorers

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age >18years

  • Ability and consent to undergo electrophysiological routine assessment

  • Informed Consent as documented by signature

  • In-patients of RehaClinic Bad Zurzach

Exclusion Criteria:
  • Previous enrolment into the current study,

  • Enrolment of the investigator, his/her family members, employees and other dependent persons

  • Cardiac pacemaker or another implanted electrical device

  • Women who are pregnant or breastfeeding

  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant

Contacts and Locations

Locations

Site City State Country Postal Code
1 KSM Bad Zurzach Bad Zurzach Aargau Switzerland 5330

Sponsors and Collaborators

  • Sleepiz AG

Investigators

  • Principal Investigator: Jens Acker, Dr., KSM Bad Zurzach

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sleepiz AG
ClinicalTrials.gov Identifier:
NCT04803552
Other Study ID Numbers:
  • 20-025-EX-KSM Bad Zurzach
First Posted:
Mar 17, 2021
Last Update Posted:
Feb 8, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sleepiz AG
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2022